登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Best response of SCT (paclitaxel and cetuximab).
Best response of SCT (paclitaxel and cetuximab).
收藏
NIAID Data Ecosystem
2026-03-13 收录
肿瘤疗效评估
化疗靶向联合治疗
数据链接：
https://figshare.com/articles/dataset/Best_response_of_SCT_paclitaxel_and_cetuximab_/20398513
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Best response of SCT (paclitaxel and cetuximab).
应用场景：
创建时间：
2022-07-28
相关数据集
Tumor MRI measurements before and after treatment.
肿瘤疗效评估
医学影像分析
Tumor MRI measurements before and after treatment.
NIAID Data Ecosystem
8
0
Supplementary Material for: Depth and Duration of Response Are Associated With Survival in Patients With Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150
肝细胞癌免疫治疗
肿瘤疗效评估
Introduction IMbrave150 established first-line atezolizumab plus bevacizumab as a global standard of care for unresectable hepatocellular carcinoma (HCC). We report exploratory analyses of association
Figshare
2025-02-27 更新
6
0
Pooled Weighted Outcomes and Direct Meta-Analysis.
肿瘤疗效评估
临床荟萃分析
CI, confidence interval; ORR, objective response rate; PFS, progression free survival; OS, overall survival.
Figshare
2015-12-02 更新
5
0
Tumor size and volume at pre- and post-chemotherapy.
肿瘤疗效评估
化疗响应
Tumor size and volume at pre- and post-chemotherapy.
NIAID Data Ecosystem
7
0
Comparison of objective response rate and toxicity in therapy subgroups by type of malignancy.
肿瘤疗效评估
治疗毒性分析
Comparison of objective response rate and toxicity in therapy subgroups by type of malignancy.
Figshare
2018-02-21 更新
5
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
